StockData

Drugs Made In America Acquisition II Corp. (DMII) stock

DMIINasdaqBlank ChecksFiscal year ends December 31Also trades as DMIIR, DMIIU
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 16, 2026
$10.24+0.00 (+0.05%)

Close on Nov 17, 2026Market cap $140.36MP/E –Yield –

Drugs Made In America Acquisition II total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Drugs Made In America Acquisition II's total debt was $450.00K at Jun 30, 2026.

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$450.00K–
Q1 FY2026Mar 31, 2026$450.00K–

More Drugs Made In America Acquisition II figures

See a number that looks wrong?